{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:08:10Z","timestamp":1786975690081,"version":"build-2736575974"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.20330","type":"journal-article","created":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T15:12:39Z","timestamp":1602515559000},"page":"e2020330","source":"Crossref","is-referenced-by-count":2,"title":["Hypertension Treatment Modality and Suicide Risk Among Veterans in Veterans Health Administration Care From 2015 to 2017"],"prefix":"10.1001","volume":"3","author":[{"given":"Kallisse R.","family":"Dent","sequence":"first","affiliation":[{"name":"Veterans Affairs (VA) Serious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health and Suicide Prevention, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron A.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Veterans Affairs (VA) Serious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health and Suicide Prevention, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"McCarthy","sequence":"additional","affiliation":[{"name":"Veterans Affairs (VA) Serious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health and Suicide Prevention, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira R.","family":"Katz","sequence":"additional","affiliation":[{"name":"VA Office of Mental Health and Suicide Prevention, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"issue":"6","key":"zoi200705r3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/sltb.2017.47.issue-6","article-title":"Risk factors for suicide and suicidal behavior relevant to emergency health care settings: a systematic review of post-2007 reviews.","volume":"47","author":"McClatchey","year":"2017","journal-title":"Suicide Life Threat Behav"},{"issue":"10","key":"zoi200705r4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13304","article-title":"Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide.","volume":"2","author":"Mamdani","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi200705r5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20f13238","article-title":"Angiotensin receptor blockers and the risk of suicide: an exercise in the critical examination of a case-control study.","volume":"81","author":"Andrade","year":"2020","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"zoi200705r6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/070674379604100713","article-title":"Case-control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population.","volume":"41","author":"Patten","year":"1996","journal-title":"Can J Psychiatry"},{"issue":"2","key":"zoi200705r7","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ajmg.b.v150b:2","article-title":"Angiotensin I-converting enzyme I\/D polymorphism and suicidal behaviors.","volume":"150B","author":"Sparks","year":"2009","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"zoi200705r8","doi-asserted-by":"publisher","first-page":"792","DOI":"10.2165\/00003495-199040060-00003","article-title":"Antihypertensive medications and depression.","volume":"40","author":"Beers","year":"1990","journal-title":"Drugs"},{"issue":"4","key":"zoi200705r9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1515\/JBCPP.2003.14.4.323","article-title":"Captopril and enalapril improve cognition and depressed mood in hypertensive patients.","volume":"14","author":"Braszko","year":"2003","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"6","key":"zoi200705r10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00228-007-0293-5","article-title":"Cardiovascular drugs and the risk of suicide: a nested case-control study.","volume":"63","author":"Callr\u00e9us","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"zoi200705r11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.mehy.2012.11.043","article-title":"Angiotensin receptor blockers for bipolar disorder.","volume":"80","author":"de G\u00f3is Queiroz","year":"2013","journal-title":"Med Hypotheses"},{"issue":"1","key":"zoi200705r12","first-page":"59","article-title":"Protective effect of irbesartan an angiotensin (AT1) receptor antagonist in unpredictable chronic mild stress induced depression in mice.","volume":"67","author":"Ayyub","year":"2017","journal-title":"Drug Res (Stuttg)"},{"issue":"1","key":"zoi200705r13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1517\/14728222.8.1.7","article-title":"Angiotensin as a target for the treatment of Alzheimer\u2019s disease, anxiety and depression.","volume":"8","author":"Gard","year":"2004","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"zoi200705r14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/0929866527666191223144000","article-title":"Exploring the evidence implicating the renin-angiotensin system (RAS) in the physiopathology of mood disorders.","volume":"27","author":"Mohite","year":"2020","journal-title":"Protein Pept Lett"},{"issue":"2","key":"zoi200705r15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists.","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol Rev"},{"issue":"1","key":"zoi200705r16","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12916-017-0916-3","article-title":"The renin-angiotensin system: a possible new target for depression.","volume":"15","author":"Vian","year":"2017","journal-title":"BMC Med"},{"issue":"1","key":"zoi200705r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2010.10.001","article-title":"Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.","volume":"36","author":"Saavedra","year":"2011","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"zoi200705r18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000218077","article-title":"Angiotensin-converting enzyme polymorphism and completed suicide: an association in Caucasians and evidence for a link with a method of self-injury.","volume":"59","author":"Fudalej","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"12","key":"zoi200705r19","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00702-006-0483-9","article-title":"Association between a functional polymorphism in the renin-angiotensin system and completed suicide.","volume":"113","author":"Hishimoto","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"zoi200705r20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/ajh\/hpu197","article-title":"Neuroprotective effects of angiotensin receptor blockers.","volume":"28","author":"Villapol","year":"2015","journal-title":"Am J Hypertens"},{"issue":"11","key":"zoi200705r21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/S0006-3223(95)00597-8","article-title":"An insertion\/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders.","volume":"40","author":"Arinami","year":"1996","journal-title":"Biol Psychiatry"},{"issue":"11","key":"zoi200705r22","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.mp.4001884","article-title":"Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism.","volume":"11","author":"Baghai","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"3","key":"zoi200705r23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00726-006-0335-9","article-title":"The role of substance P in stress and anxiety responses.","volume":"31","author":"Ebner","year":"2006","journal-title":"Amino Acids"},{"issue":"3","key":"zoi200705r25","doi-asserted-by":"publisher","first-page":"146S","DOI":"10.1177\/1077558703257000","article-title":"Prevalence and costs of chronic conditions in the VA health care system.","volume":"60","author":"Yu","year":"2003","journal-title":"Med Care Res Rev"},{"issue":"10","key":"zoi200705r26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13284","article-title":"Concerns raised by a study of suicide as an adverse drug effect: replicating findings from real-world data.","volume":"2","author":"Katz","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi200705r27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2165\/00129784-200303030-00002","article-title":"Risk of suicide in users of cardiovascular drugs: a review of the epidemiological evidence.","volume":"3","author":"Jepsen","year":"2003","journal-title":"Am J Cardiovasc Drugs"},{"key":"zoi200705r1","volume-title":"The Structure of Scientific Revolutions","author":"Kuhn","year":"1970"},{"key":"zoi200705r2","volume-title":"On Suicide","author":"Durkheim","year":"2007"},{"key":"zoi200705r24","unstructured":"Department of Veteran Affairs Office of Mental Health and Suicide Prevention. 2019 National Veteran Suicide Prevention Annual Report. Accessed January 7, 2020. https:\/\/www.mentalhealth.va.gov\/docs\/data-sheets\/2019\/2019_National_Veteran_Suicide_Prevention_Annual_Report_508.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2771379\/dent_2020_oi_200705_1601396093.33712.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T15:13:02Z","timestamp":1602515582000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2771379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20330","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}